News and Media : 2018 :

Shockwave therapy: An innovative treatment for erectile dysfunction

Preliminary clinical studies have demonstrated that Shockwave therapy may effectively treat erectile dysfunction (ED). At the University of Miami we are conducting a pilot study in the US territory with the Renova–ED device that uses low energy shockwave delivered by special device uniquely suited to treat the penis.
Our study is aimed to determine the safety and efficacy of this new type of ED treatment. Shockwave therapy appears to increase blood flow to the penis and recruit stem cells that will enable better erections.

Briefly,

Who may qualify for this study:

  • Man from 30 to 80 years old with mild ED who have tried Viagra / Cialis or who have not tried these medications you may be eligible to participate in the study
  • ED lasting over 6 months and not more than 5 years
  • Normal testosterone levels
  • If diabetic, HgbA1C level ≤ 7.5% within 1 month prior to enrollment

Who may not qualify for this study if:

  • History of radical prostatectomy or extensive pelvic surgery ever
  • Past radiation therapy of the pelvic region within 12 months prior to enrollment
  • Recovering from any cancer within 12 months prior to enrollment
  • Testosterone level <300 or >1000 ng/dL within 1 month prior to enrollment
  • HgbA1C level > 7.5% within 1 month prior to enrollment

For more informations about the clinical trial, click here

To enroll in this study please contact Dr. Manuel Leyba Molina at (305) 243 – 4873 (ext. 1176) or m.molina.leyba@miami.edu